Our study group has shown that CXCR4-targeted imaging using the radiopharmaceutical [68Ga]Ga-PentixaFor is an effective image tool in staging a variety of neoplasms, especially multiple myeloma, mantle cell lymphoma, small cell lung cancer, and adrenocortical neoplasms [7]. The gene discussed is CXCR4; the disease is neoplasm.